Therapeutic strategies and emergence of multiresistant bacterial strains
- 24 September 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 5 (1), 45-51
- https://doi.org/10.1007/s11739-010-0447-9
Abstract
Spontaneous bacterial peritonitis (SBP) is one of the most serious complications occurring in cirrhotic patients with ascites. Therefore, an effective therapy is always required starting immediately after diagnosis. There are three aims of therapy: (1) to eradicate the bacterial strain responsible of the infection; (2) to prevent renal failure; and (3) to prevent SBP recurrence. The first end point is achievable by means of a large-spectrum antibiotic therapy. Empirical antibiotic therapy can be started with a third-generation cephalosporin, amoxicillin–clavulanate or a quinolone. The effectiveness of antibiotics should be verified by determining the percent reduction of polymorphonuclear cells count in the ascitic fluid. If bacteria result to be resistant to the empirical therapy, a further antibiotic must be given according to the in vitro bacterial susceptibility. In most cases, a 5-day antibiotic therapy is enough to eradicate the bacterial strain. Severe renal failure occurs in about 30% of patients with SBP, independently of the response to antibiotics, and it is associated with elevated mortality. The early administration of large amount of human albumin showed to be able to reduce the episodes of renal failure and to improve survival. After the resolution of an episode of SBP, the recurrence is frequent. Therefore, an intestinal decontamination with oral norfloxacin has been shown to significantly reduce this risk and is widely practised. However, such a long-term prophylaxis, as well as the current increased use of invasive procedures, favours the increase of bacterial infections, including SBP, contracted during the hospitalization (nosocomial infections) and sustained by multi-resistant bacteria. This involves the necessity to use a different strategy of antibiotic prophylaxis as well as a more strict surveillance of patients at risk.This publication has 56 references indexed in Scilit:
- Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)Hepatology International, 2008
- Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flowJournal of Hepatology, 2004
- Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus documentJournal of Hepatology, 2000
- Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trialJournal of Hepatology, 1998
- Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortalityJournal of Hepatology, 1998
- Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter studyJournal of Hepatology, 1995
- Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitisJournal of Hepatology, 1994
- Immunological aspects of new quinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitisJournal of Hepatology, 1986
- Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and PrognosisJournal of Hepatology, 1984